Management of acquired resistance to ALK inhibitors: Repeat biopsy to characterize mechanisms of resistance does not significantly impact clinical outcomes

by Naiyarat Prasongsook, Thanyanan Reungwetwattana
Published 2022

Glycoproteomic analysis reveals aberrant expression of complement C9 and fibronectin in the plasma of patients with colorectal cancer

by Juthamard Chantaraamporn, Voraratt Champattanachai, Amnart Khongmanee, Chris Verathamjamras, Naiyarat Prasongsook, Kanokwan Mingkwan, Virat Luevisadpibul, Somchai Chutipongtanate, Jisnuson Svasti
Published 2020